Global Device Approvals, Weekly Snapshot: Tandem Diabetes Win

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, Tandem Diabetes Care gained US FDA go-ahead for the first "interoperable" insulin pump.

Approved

Two novel device or indication approvals were added to Medtech Insight's Approvals Tracker last week. Among them, Tandem Diabetes Care Inc. netted a first with US FDA. On Feb. 14, the agency granted a de novo classification to a version of Tandem's t:Slim X2 insulin pump with technology allowing it to be used with a variety of different components that make up diabetes therapy systems.

Previously, insulin pumps have either been cleared as completely standalone devices or as part of a single, predefined diabetes management...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Approvals

More from Policy & Regulation